Multiple Clinical Trials of VELCADE(R) (Bortezomib) for Injection Based Therapies Demonstrate High Complete Remission Rates in Patients with Newly Diagnosed Multip... ( CHICAGO May 31 /- Millennium Phar...)

HOME >> MEDICINE >> TECHNOLOGY

Multiple Clinical Trials of VELCADE(R) (Bortezomib) for Injection Based Therapies Demonstrate High Complete Remission Rates in Patients with Newly Diagnosed Multiple Myeloma

Date:5/31/2008

CHICAGO, May 31 /PRNewswire/ -- Millennium Pharmaceuticals, The Takeda Oncology Company, today announced the presentation of results from three clinical trials of VELCADE based therapies that showed consistently high complete remission(1) (CR) rates in patients with newly diagnosed multiple myeloma (MM). CR is one of the best predictors of long-term survival. These three studies were selected for oral presentation at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Illinois, May 30 - June 3, 2008. Highlights included:

-- VELCADE, cyclophosphamide, and dexamethasone (CyBorD) demonstrated a

CR rate of 46 percent prior to transplant and 72 percent

post-transplant

-- VELCADE, DOXIL and dexamethasone (PAD or VcDD) prior to transplant

showed a CR rate of 21 percent which increased to 59 percent

post-transplant

-- VELCADE, lenalidomide and dexamethasone (VRD) showed a CR rate of 35

percent at maximum planned dose and a 100 percent overall response

rate.

(Logo: http://www.newscom.com/cgi-bin/prnh/19991220/MLNMLOGO )

"The goal of first-line therapy is to rapidly achieve the deepest and most durable response possible," said Nancy Simonian, M.D., Chief Medical Officer, Millennium. "VELCADE based combinations produce among the highest CR rates that are similar to those achieved by high dose therapy and transplantation. These very strong results underscore the critical role of VELCADE in patients with newly diagnosed multiple myeloma."

Efficacy of Induction with CyBorD in Newly Diagnosed Multiple Myeloma (Abstract #8517)

This study of CyBorD was designed to determine response in patients with newly diagnosed multiple myeloma. The results showed the status of 28 evaluable patients, who received cyclophosphamide at 300 mg/m2 on days 1, 8, 15, 22, VELCADE at 1
'/>"/>

SOURCE Millennium Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7
Related medicine technology :

1. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
2. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
3. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
4. Kosan Opens Registration Program for Lead Hsp90 Inhibitor, Tanespimycin, in Multiple Myeloma
5. Multiple NIH Phase 2 HIV Vaccine Trials Using Vicals Technology Produce Encouraging Results
6. TorreyPines Therapeutics Initiates a Phase I Multiple Dose Clinical Trial of Tezampanel
7. Kosan Receives Completed Special Protocol Assessment for TIME-1 Pivotal Phase 3 Trial of Tanespimycin in Multiple Myeloma
8. TorreyPines Therapeutics Completes Phase I Multiple Dose Clinical Trial of NGX267, a Selective M1 Agonist for the Potential Treatment of Cognitive Impairment Associated with Schizophrenia
9. Pharmacopeia Announces Positive Results from Phase 1 Multiple Ascending Dose Study of PS433540 (DARA)
10. Phase III Clinical Trial in Newly Diagnosed Multiple Myeloma Stopped Early Due to Highly Significant Efficacy Advantage of VELCADE(R) (Bortezomib) for Injection Based Therapy Across All Endpoints
11. Velcura Therapeutics, Inc. Reports Positive Pre-IND Meeting With FDA and Plans Early Clinical Trials for New Drug to Treat Multiple Myeloma Bone Disease

Post Your Comments:

(Date:5/21/2013)... Regulus Therapeutics Inc . ( NASDAQ: RGLS ... of innovative medicines targeting microRNAs, today announced that ... Officer and Executive Vice President, Finance, will present a ... Conference on Wednesday, May 29, 2013 at 3:30 pm ... Boston Waterfront Hotel. The presentation will be ...

(Date:5/21/2013)... , May 21, 2013 On ... impressive new product developments at the Special Libraries Association PHTD ... of unerring focus on product literature databases and workflow solutions ... the occasion," said founding director Nigel Johnson ... of benefit to our clients and what better forum to ...

(Date:5/21/2013)... PARK, N.J. , May 21, 2013 /PRNewswire/ ... the launch of the new Armada corporate website ... to clearly communicate Armada,s unique and first-to-market services ... service company focused on the specialty pharmacy industry. ... continued expansion of the Armada business model in ...

Breaking Medicine Technology:Regulus to Present at Deutsche Bank 38th Annual Healthcare Conference 2 Pi2 Solutions' 10th Anniversary Heralds New Corporate Image as Platinum Sponsor of SLA PHT Meeting in Philadelphia 2 Pi2 Solutions' 10th Anniversary Heralds New Corporate Image as Platinum Sponsor of SLA PHT Meeting in Philadelphia 3 Armada Announces New Corporate Website to Showcase Expanded Services to Specialty Pharmacy Marketplace 2

[0] Regulus to Present at Deutsche Bank 38th Annual Healthcare Conference [0] Pi2 Solutions' 10th Anniversary Heralds New Corporate Image as Platinum Sponsor of SLA PHT Meeting in Philadelphia [0] Armada Announces New Corporate Website to Showcase Expanded Services to Specialty Pharmacy Marketplace

... N.J., April 8, 2011 Unity Management Group, ... a Health Resource Company specializing in Physician, and ... Technologies, along with Pharmacy Instrumentation, Calibration, Data Acquisition, ... Inc. ("UNITY") (OTCMARKETS: UYMG) announced today it has ...

... 8, 2011 Xeridiem™ Medical Devices (xeridiem) is ... Excellence Award (MDEA). This international award was for ... Clearance System (PleuraFlow ATC), developed by Clear Catheter ... the design and development for manufacturability, supported the ...

Cached Medicine Technology:Unity Management Group, Inc. MCC Receives First Major Order for B&D Italia Tablet Press 2 Unity Management Group, Inc. MCC Receives First Major Order for B&D Italia Tablet Press 3 Xeridiem Medical Devices Receives MD+DI 2011 Medical Design Excellence Award (MDEA). 2

Unity Management Group, Inc. MCC Receives First Major Order for B&D Italia Tablet Press Xeridiem Medical Devices Receives MD+DI 2011 Medical Design Excellence Award (MDEA).

(Date:5/21/2013)... 2013 Global Proving Ground (GPG), a ... largest online retailer of health and fitness supplements, are ... show, Warrior Island. “We cast the show by ... Twitter, with our unique social networking platform,” states show’s ... fighters on an island in the Pacific Ocean, where ...

(Date:5/21/2013)... 2013) A paper recently published in the ... physicians and scientists at the University of Colorado School ... for pulmonary fibrosis can be used to identify individuals ... looked at a fairly common variant of the gene ... the mucous produced by the bronchial tubes. While this ...

(Date:5/21/2013)... Department of Defense Serum Repository (DoDSR), University of Cincinnati ... inflammatory bowel disease (IBD), which could help with earlier ... shown symptoms. , This finding, the first of its ... being presented via podium presentation by staff from Walter ... 2013, being held May 18-21 in Orlando, Fla. ...

(Date:5/21/2013)... New York (PRWEB) May 21, 2013 ... surgery robot lawsuit is nearing its conclusion in ... to Bloomberg.com, during closing statements yesterday, an attorney for ... alleging the company wanted to tie sales and services ... all the training to keep control of surgeons, to ...

(Date:5/21/2013)... (PRWEB) May 21, 2013 Go Classy ... today that they have redesigned their website featuring ... beach, pool, hot tubs, bars and dining. The website, ... resort including sales and guest reviews, will now have ... Jamaica itself, including pages on culinary local recipes, flora ...

Breaking Medicine News(10 mins):Health News:Bodybuilding.com Partners with Global Proving Ground’s New Reality Show Warrior Island 2 Health News:Bodybuilding.com Partners with Global Proving Ground’s New Reality Show Warrior Island 3 Health News:Researchers find genetic risk factor for pulmonary fibrosis 2 Health News:Biomarkers discovered for inflammatory bowel disease 2 Health News:Da Vinci Surgery Robot Lawsuit News: Bernstein Liebhard LLP Comments on Closing Arguments in Nation’s First Da Vinci Lawsuit Trial 2 Health News:Da Vinci Surgery Robot Lawsuit News: Bernstein Liebhard LLP Comments on Closing Arguments in Nation’s First Da Vinci Lawsuit Trial 3 Health News:Da Vinci Surgery Robot Lawsuit News: Bernstein Liebhard LLP Comments on Closing Arguments in Nation’s First Da Vinci Lawsuit Trial 4 Health News:The Oldest and Original Nudist Travel Agency for NResort Announced Today a Redesigned Website Featuring Information on Culinary Events, Flora and Fauna, and Photography 2

[0] Bodybuilding.com Partners with Global Proving Ground’s New Reality Show Warrior Island [0] Researchers find genetic risk factor for pulmonary fibrosis [0] Biomarkers discovered for inflammatory bowel disease [0] Da Vinci Surgery Robot Lawsuit News: Bernstein Liebhard LLP Comments on Closing Arguments in Nation’s First Da Vinci Lawsuit Trial [0] The Oldest and Original Nudist Travel Agency for NResort Announced Today a Redesigned Website Featuring Information on Culinary Events, Flora and Fauna, and Photography

... Cancer Patients in HELIOS HospitalsBERLIN, March 10 ... gain access to the most modern radiotherapy treatments with ... is acquiring nine linear accelerators from Varian Medical Systems ... equipped with RapidArc(TM) technology for fast and comfortable treatments. ...

... awareness for children and adults with autismFAIRFIELD, Conn. ... Network ( www.AutismSupportNetwork.com ) and the Israeli Society ... announced an international alliance to help foster support ... autism spectrum disorder (ASD). The partnership provides for ...

... March 10 More physician leaders are embracing technological ... consider them clunky and unresponsive to their needs.Those are ... American College of Physician Executives (ACPE). The findings were ... Journal, ACPE,s journal of medical management.ACPE conducted the same ...

... HOUSTON, March 10 InPlace Medical Solutions ... pioneering telemedicine healthcare services for Scorpion Offshore ... ongoing pilot project makes Scorpion Offshore the ... with the full-service system of advanced healthcare, ...

... /PRNewswire-FirstCall/ - Labopharm Inc. (TSX: DDS; NASDAQ: DDSS ... of the Company, will present at the Cowen and Company ... Place, on Wednesday, March 18, 2009 at 11:00 a.m. ET. ... presentation by visiting the "Events" section of the homepage of ...

... Quarter Adjusted FIFO EBITDA Increases 4.3% to $26.1 Million, ... Full Year Adjusted FIFO EBITDA Increases 15% to ... Year Net Cash Provided by Operating Activities Increases 130% ... $17.4 Million and Full Year Net Loss of $72.8 ...

Leading German Healthcare Group Selects Equipment and Software from Varian Medical Systems for Major Replacement Project Autism Support Network and the Israeli Society for Autistic Children Form International Alliance Survey Results: Health Care Technology Advances as Physician Frustration Grows Scorpion Offshore Inc. Pilot Project With InPlace Medical Solutions Sets New Standard for Offshore Medical Services Labopharm to present at Cowen 29th Annual Health Care Conference Duane Reade Holdings, Inc. Reports Fourth Quarter and Full Year 2008 Results

... Intersurgical Incorporated manufactures high ... and moisture exchangers, ventilator ... hand-held nebulizers and an ... and connectors for anesthesia ...

... The Ulti-Mist™ HME product line has the ... pediatrics to adults and from intubated patients ... superior humidification for both anesthesia and critical ... HME/Filters provide maximum protection for patients and ...

... hygroscopic condenser humidifiers (HCH) capture the patient`s ... in the inspired gas. Small and compact, ... and hygroscopic benefits. Depending on the tidal ... small-volume model., ,The adult HCH is ...

Medicine Products:

Filta-Therm® with Integrated Y-piece and Flextube Patient Connection Filta-Therm® with Flextube Patient Connection Medisize Ulti-Mist HME/F Humidaire I And Omniflex Connector